Status:
COMPLETED
Ulcer Prevention II
Lead Sponsor:
AstraZeneca
Conditions:
NSAID Associated Gastric Ulcers
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers, in patients deemed to be at risk, with either esomep...
Eligibility Criteria
Inclusion
- No active/current gastric or duodenal ulcer on baseline endoscopy.
- A clinical diagnosis of a chronic condition that requires daily NSAID treatment for at least 6 months.
- Other inclusion criteria, as defined in the protocol.
Exclusion
- 1\. History of esophageal, gastric or duodenal surgery, except the simple closure of an ulcer.
- 2\. History of severe liver disease, including (but not limited to) cirrhosis and acute or chronic hepatitis.
- 3\. Other criteria, as defined in the protocol.
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2003
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00629928
Start Date
February 1 2001
End Date
March 1 2003
Last Update
January 25 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.